1. Home
  2. SSL vs GRFS Comparison

SSL vs GRFS Comparison

Compare SSL & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sasol Ltd.

SSL

Sasol Ltd.

HOLD

Current Price

$13.51

Market Cap

5.6B

Sector

Energy

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.68

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSL
GRFS
Founded
1950
1940
Country
South Africa
Spain
Employees
27411
25247
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SSL
GRFS
Price
$13.51
$7.68
Analyst Decision
Sell
Hold
Analyst Count
1
2
Target Price
N/A
$10.15
AVG Volume (30 Days)
1.5M
590.7K
Earning Date
04-24-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.79
$4.49
Revenue Next Year
$4.39
$6.42
P/E Ratio
$13.51
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$3.90
$7.39
52 Week High
$14.37
$11.14

Technical Indicators

Market Signals
Indicator
SSL
GRFS
Relative Strength Index (RSI) 56.03 39.40
Support Level $11.82 $7.39
Resistance Level $13.68 $9.78
Average True Range (ATR) 0.33 0.22
MACD -0.09 -0.06
Stochastic Oscillator 57.66 16.06

Price Performance

Historical Comparison
SSL
GRFS

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: